Regen BioPharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Regen BioPharma's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $236,560. The net income dropped to -$867,252 and profit margin reached -367%. Total operating expenses were $577,534.
Profit Margin
| 2015 | 192K | -11.19M | -5830.81% |
|---|---|---|---|
| 2016 | 100K | -7.75M | -7750.59% |
| 2017 | 110K | -5.83M | -5308.22% |
| 2018 | 100K | -4.71M | -4715.2% |
| 2019 | 110K | -4.32M | -3931.03% |
| 2020 | 110K | 1.78M | 1626% |
| 2021 | 171.19K | -7.13M | -4166.05% |
| 2022 | 235.51K | 5.48M | 2330.99% |
| 2023 | 236.56K | 1.02M | 432.66% |
| 2024 | 236.56K | -867.25K | -366.61% |
RGBP Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 236.56K | 236.56K | 235.51K | 171.19K | 110K | 110K | 100K | 110K | 100K | 192K |
Cost of revenue | 77.21K | 0 | 50K | 25K | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 159.34K | 236.56K | 185.51K | 146.19K | 110K | 110K | 100K | 110K | 100K | 192K |
Operating exp. | ||||||||||
Research and development | 153.68K | 212.29K | 275.38K | 36.70K | 13.28K | 45.60K | 374.43K | 1.14M | 671.09K | 282.29K |
Selling and marketing | 0 | 60K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 577.53K | 923.51K | 575.12K | 371.96K | 319.31K | 866.78K | 1.52M | 2.62M | 3.05M | 2.17M |
Operating income | -418.18K | -686.95K | -339.60K | -200.77K | -209.31K | -756.78K | -1.42M | -2.51M | -2.95M | -1.97M |
Other income (expenses), net | -449.06K | 1.84M | 2.78M | -6.56M | 3.62M | -1.86M | -1.73M | -3.32M | -4.74M | -231.44K |
Income before tax | -867.25K | 1.15M | 2.44M | -6.76M | 3.41M | -2.62M | -4.71M | -5.83M | -7.75M | -11.19M |
Income tax expense | 0 | 0 | -3.04M | 366.79K | 1.62M | 1.70M | 3.01M | 589.20K | 45.22K | 20.53K |
Net income | -867.25K | 1.02M | 5.48M | -7.13M | 1.78M | -4.32M | -4.71M | -5.83M | -7.75M | -11.19M |
Earnings per share | ||||||||||
Basic EPS | -0.21 | 0.29 | 1.75 | -3.55 | 1.9 | -3.13 | -46.5 | -61.93 | -90.94 | -190.43 |
Diluted EPS | -0.21 | 0.29 | 1.75 | -3.55 | 1.9 | -3.13 | -46.5 | -61.93 | -90.94 | -190.43 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |